<DOC>
	<DOCNO>NCT01753180</DOCNO>
	<brief_summary>A prospective , multi-center , double blind , 2 stage , placebo-controlled , phase II study , evaluate acute intra-coronary injected collagenase prior routine standard-of-care percutaneous revascularization procedure subject chronic total coronary artery occlusion ( CTOs ) .</brief_summary>
	<brief_title>Total Occlusion Study Coronary Arteries - 5</brief_title>
	<detailed_description />
	<criteria>Male female patient &gt; 18 year age clinically driven , plan PCI target CTO , major epicardial coronary artery , without plan revascularization coronary stenosis/stenoses major epicardial segment . Target CTO must great equal 3 calendar month prior Screening Target CTO must meet protocol define criterion entry Patient receive course optimal antiischemic medical therapy ( least 2 antianginal agent maximum tolerated antianginal therapy ) Documented chest radiation exposure &gt; 4.0 Gray within 8 week Day 0 Target vessel occlude stent , saphenous vein graft Patient ACS &lt; 4 week Screening , attributable coronary vessel Patient nonhealed dissection plane extend point adjacent coronary lumen distal target CTO Patient know suspect target vessel perforation within 30 day Day 0 Angiographic exclusion criterion define protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>CTO</keyword>
	<keyword>PCI</keyword>
	<keyword>Angioplasty</keyword>
</DOC>